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We have assessed two approaches to sequencing complete human cytomegalovirus (HCMV)
genomes (236 kbp) in DNA extracted from infected cell cultures (strains 3157, HAN13, HAN20
and HAN38) or clinical specimens (strains JP and 3301). The first approach involved amplifying
genomes from the DNA samples as overlapping PCR products, sequencing these by the Sanger
method, acquiring reads from a capillary instrument and assembling these using the Staden
programs. The second approach involved generating sequence data from the DNA samples by
using an Illumina Genome Analyzer (IGA), processing the filtered reads by reference-independent
(de novo) assembly, utilizing the resulting sequence to direct reference-dependent assembly of
the same data and finishing by limited PCR sequencing. Both approaches were successful. In
particular, the investigation demonstrated the utility of IGA data for efficiently sequencing
genomes from clinical samples containing as little as 3% HCMV DNA. Analysis of the genome
sequences obtained showed that each of the strains grown in cell culture was a mutant. Certain of
the mutations were shared among strains from independent clinical sources, thus suggesting that
they may have arisen in a common ancestor during natural infection. Moreover, one of the strains
(JP) sequenced directly from a clinical specimen was mutated in two genes, one of which
encodes a proposed immune-evasion function, viral interleukin-10. These observations imply that
HCMV mutants exist in human infections.
INTRODUCTION
Human cytomegalovirus (HCMV; species Human herpes-
virus 5) has the largest genome of any known human virus,
at 236 kbp in size (Dolan et al., 2004). The genome is a
linear, double-stranded DNA molecule consisting of two
unique regions, each flanked by inverted repeats. The
structure is represented as ab-UL-b9a9c9-US-ca, where UL
and US denote the long and short unique regions and
ba/b9a9 and ca/c9a9 indicate the inverted repeats. In wild-
type HCMV strain Merlin (GenBank accession no.
AY446894), the sizes of UL and US are 193 019 and
35 482 bp, respectively, and those of a/a9, b/b9 and c/c9 are
578, 746 and 1959 bp, respectively.
Many studies have shown that HCMV strains are
impressively divergent in a subset of genes encoding
The GenBank/EMBL/DDBJ accession numbers for the genome
sequences of HCMV strains 3157, JP, HAN13, HAN20, HAN38 and
3301 are GQ221974, GQ221975, GQ221973, GQ396663,
GQ396662 and GQ466044, respectively. The Illumina Genome
Analyzer sequence datasets for HCMV strains HAN13, HAN20,
HAN38 and 3301 are available from the corresponding author.
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membrane-associated or secreted proteins (e.g. Dolan et al.,
2004; Murphy et al., 2003; Pignatelli et al., 2004). Each of
these hypervariable genes exists as several highly diverged
clusters of alleles, with a much lower level of allelic
variation evident within individual clusters. The sequences
of particular alleles are stable on short timescales in
patients (Hassan-Walker et al., 2004; Stanton et al., 2005)
and during cell culture (Lurain et al., 2006). These
observations suggest that hypervariation is a result of
immune selection and that the allelic clusters have a long
history, perhaps having emerged during the evolution of
populations of early humans or their predecessors (Bradley
et al. 2008; Dolan et al., 2004). Also, there is extensive
evidence that recombination has occurred during HCMV
evolution, and that HCMV infections frequently involve
multiple strains (e.g. Arav-Boger et al., 2005; Bates
et al., 2008; Bradley et al., 2008; Mattick et al., 2004;
Puchhammer-Sto¨ckl & Go¨rzer, 2006; Rasmussen et al.,
2003; Yan et al., 2008). These factors add significant
complexities to assessments of the associations between the
genetic constitution of HCMV strains and disease out-
come. Further work investigating HCMV genomes in
clinical material is required in order to facilitate evalua-
tions of the extent of strain variation, the occurrence of
mixed infections and the biological correlates of particular
genetic configurations.
All of the HCMV genome sequences published to date
(Table 1) have been derived from strains grown in cell
culture, which is known to exert selective pressure and
induce genetic adaptations, some of which are extensive
(Cha et al., 1996; Dolan et al., 2004; Prichard et al., 2001).
With two recent exceptions discussed below, these
sequences were determined by random shotgun cloning
of standard bacterial plasmid libraries, bacterial artificial
chromosomes (BACs) or purified virion DNA, followed by
Sanger sequencing. To sequence HCMV genomes in
clinical material, it is important to avoid cell culture,
because of its mutagenic effects and the likelihood that not
all strains present will transfer successfully from a
specimen. Also, it is important not to utilize bacterial
plasmids or BACs, since such clones may not fully
represent the virus populations from which they origi-
nated. In this paper, we explore two approaches to
sequencing complete HCMV genomes from infected cell
cultures and clinical specimens that meet these require-
ments, and that also cope with the presence of high
proportions of cellular DNA in such substrates.
The first approach (PCR sequencing) involved generating
numerous, overlapping PCR products from HCMV
genomes and analysing them by Sanger sequencing. This
overcomes the presence of cellular DNA by amplifying
HCMV sequences selectively. It amounts to an extension of
a method that has been used by many researchers to
analyse selected regions of HCMV genomes, in some
studies to a substantial extent (Brondke et al., 2007; Dolan
et al., 2004).
The use of an Illumina Genome Analyzer (IGA) formed the
basis of the second approach (IGA sequencing). This high-
throughput instrument generates such a large number of
sequence reads that a virus genome can be sequenced even
when diluted substantially by cellular DNA. Genome
sequences may be assembled from IGA data by two
strategies, each of which has advantages. Reference-
dependent assembly (DA) involves aligning the reads with
a reference sequence, whereas reference-independent (de
novo) assembly (IA) deduces long contiguous sequences
(contigs) from the reads alone. DA is likely to cover a
genome more comprehensively than IA, and in a manner
that does not contain erroneously joined regions. On the
other hand, IA, by not requiring a reference, is not biased
by presumptions made about the target sequence.
We used DA previously to sequence strain AD169 variant
UC (varUC) and strain Towne varL from samples that
contained high proportions of HCMV DNA (Bradley et al.,
2009). These are the two exceptions mentioned above
(Table 1). In the present paper, we have assessed the utility
of DA and IA for sequencing HCMV genomes from
Table 1. Published HCMV genome sequences
HCMV strain Method Substrate GenBank accession no. Reference
AD169 varUK Sanger Plasmids BK000394 Chee et al. (1990)
AD169 varATCC Sanger BAC AC146999 Murphy et al. (2003)
FIX Sanger BAC AC146907 Murphy et al. (2003)
PH Sanger BAC AC146904 Murphy et al. (2003)
TB40/E Sanger BAC EF999921 Sinzger et al. (2008)
Toledo Sanger BAC AC146905 Murphy et al. (2003)
Towne varL Sanger BAC GQ121041 M. McVoy (unpublished data)
Towne varS Sanger BAC AC146851 Murphy et al. (2003)
AY315197 Dunn et al. (2003)
TR Sanger BAC AC146906 Murphy et al. (2003)
Merlin Sanger Virion DNA AY446894 Dolan et al. (2004)
AD169 varUC IGA Virion DNA FJ527563 Bradley et al. (2009)
Towne varL IGA Infected cell DNA FJ616285 Bradley et al. (2009)
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infected cell cultures and clinical specimens containing
much lower proportions of HCMV DNA. We developed a
strategy for analysing HCMV genomes by IGA sequencing
that consists of processing filtered reads by IA, then using
the resulting sequence as a reference in DA in order to
inspect the read alignment and correct any errors, and
finally finishing by limited PCR sequencing.
RESULTS
HCMV genomes sequenced
The sequences of six HCMV strains were determined, some
by more than one method (Table 2). Strains 3157, JP and
HAN13 were analysed by PCR sequencing, and strains
HAN13, HAN20, HAN38 and 3301 by IGA sequencing.
IGA data were assembled by two strategies, DA and IA,
and, during the latter process, HCMV Gap4 contigs were
aligned by using a cognate scaffold (IAC) or a generic
scaffold (IAG). The analysis was supplemented by IAC of
data reported previously for strains AD169 varUC and
Towne varL (Bradley et al., 2009).
PCR sequencing
The PCR sequencing approach was successful and, as it has
been used previously in many studies for analysing regions
of HCMV genomes, it is not elaborated further. However,
IGA sequencing is a novel approach that has been utilized
with HCMV only for DA of strains AD169 varUC and
Towne varL, and is expanded upon below.
IGA sequencing: reference-dependent assembly
IGA sequences were assembled in the present study by DA
for strains HAN13 and 3301 (Table 2). A summary of the
results is provided in Table 3.
The reference used for strain HAN13 was generated from
the genome determined by PCR sequencing, and, as
anticipated, needed no improvements (i.e. the sequences
derived by the two methods were identical). The reference
used for strain 3301 was constructed by inserting strain
3301 sequences generated by PCR sequencing into a strain
Merlin backbone. The strain 3301 PCR sequences had
either been published previously (Dolan et al., 2004;
GenBank accession numbers are given below) or were
produced for the present study. They totalled 57 977 bp
(approx. 25%) of the reference: 18 452 bp containing genes
RL5A to UL11 and parts of flanking genes RL1 and UL13
(AY446862), 2820 bp containing genes UL73, UL74,
UL74A and parts of flanking genes UL72 and UL75,
6096 bp containing gene UL111A and parts of flanking
genes UL105 and UL112 (AY446874), 25 616 bp containing
genes UL120 to UL150 and part of the flanking gene UL119
(AY446864), 2011 bp extending from AY446864 into the
b9, a9 and part of the c9 inverted repeats, and 2982 bp
Table 2. HCMV strains analysed: sources, sequencing methods and mutations
HCMV
strain
Source Sequencing method* Genes
mutated
Clinical Geographical DNA Passage PCR DA IAC IAG
3157 Urine from a congenitally
infected infant
Cardiff, UK Fibroblast culture
virions
3 3 RL13, UL40,
UL128
JP Post-mortem prostate
tissue from an AIDS
patient
London, UK Clinical material 0 3 RL5A,
UL111A
AD169
varUCD
Adenoid tissue Bethesda, MD,
USA
Fibroblast culture
virions
Many 3 3 Several
Towne
varLD
Urine from a congenitally
infected infant
Philadelphia,
PA, USA
Fibroblast culture
cells
Many 3 3 Several
HAN13 Bronchoalveolar lavage Hannover,
Germany
Fibroblast culture
cells
3 3 3 3 RL5A
HAN20 Bronchoalveolar lavage Hannover,
Germany
Fibroblast culture
cells
2 3 US9
HAN38 Bronchoalveolar lavage Hannover,
Germany
Fibroblast culture
cells
2 3 RL6, US9
3301 Urine from a congenitally
infected infant
Cardiff, UK Clinical material 0 3 3 3 None
*DA, Reference-dependent assembly of IGA data; IAC, reference-independent assembly of IGA data using a cognate scaffold at the Gap4 stage; IAG,
reference-independent assembly of IGA data using a generic scaffold at the Gap4 stage. 3 indicates that the method was used.
DDA of IGA data, passage histories and identities of mutated genes have been reported previously for strains AD169 varUC and Towne varL
(Bradley et al., 2009).
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containing genes US34 and US34A and part of gene US32.
The read consensus was extracted from the DA and used as
an improved reference, thus correcting mismatches due to
components in the initial reference that had originated
from strain Merlin. Residual gaps in the read consensus
due to insertions/deletions (indels) or clustered mis-
matches were remedied by utilizing an alignment of
previously determined HCMV sequences as a guide to
producing a further improved reference by reiterative local
assembly. DA using this reference left four small gaps in the
read consensus. One was located at the left end of UL
(including the junction with the adjacent b inverted
repeat), one in a (G+C)-rich region near the origin of
DNA replication, and two in tandem, direct repeats of
undetermined lengths (one a 3 nt reiteration and the other
a 1 nt reiteration or homopolymeric tract). These gaps
were resolved by PCR sequencing. At the conclusion of the
assembly process, a total of 3% of the reads aligned with
the final sequence.
IGA sequencing: reference-independent assembly
An example of the output of the earlier stages of IA is given
for strain Towne varL in Table 4, and the output for this
and the other strains at the later stages is listed in Table 3.
Thus, for strain Towne, 11 filtered datasets, in addition to
the unfiltered dataset assembled with two values of k, were
employed in 13 assemblies (Table 4). A total of 2087
pooled IA contigs was generated (the sum of the ‘all
contigs’ column in Table 4). From the 1664 pooled, non-
redundant IA contigs derived from these, 96 Phrap contigs
and then nine HCMV Phrap contigs were produced, which
were merged by IAC into three HCMV Gap4 contigs
(Table 3).
For all strains analysed, differences between the HCMV
Gap4 contigs and the final sequence were few. They had
several origins: errors in the HCMV Gap4 contigs resulting
from IA (Table 3), poor base calling at specific locations in
reads on one strand, single nucleotide polymorphisms
(SNPs) and ambiguities in the lengths of tandem repeats.
For tandem repeats, in some instances ambiguities were
not solved uniquely for homopolymeric tracts longer than
about 12 nt either by local reiterative DA or by PCR
sequencing, probably because of heterogeneity in the virus
genome.
Strains AD169 varUC, Towne varL, HAN13 and 3301 were
processed by IAC (Table 2). Strain AD169 varUC contains
a mixture of two genomes, the major one lacking a 3.7 kbp
sequence consisting of the c9 inverted repeat and the left
end of US, and the minor one being intact in this region
(Bradley et al., 2009). The single HCMV Gap4 contig
covered the major genome sequence entirely (Table 3) and
contained a single error. Similarly, the HCMV Gap4
contigs obtained for strains Towne varL, HAN13 and 3301
covered the great majority of the genomes in relatively few
contigs, and most contained a small number of errors.T
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Strains HAN20, HAN38 and 3301 were processed by IAG
(Table 2). No prior sequence information was available for
strains HAN20 or HAN38 and, although the strain 3301
sequence had already been determined by IAC, the IGA
data were analysed afresh. The HCMV Gap4 contigs
obtained for strains HAN20 and HAN38 covered the great
majority of the genomes in relatively few contigs, with a
small number of errors. The state of completeness of the
HCMV Gap4 contigs for strain 3301 was the same as that
resulting from IAC.
All of the sequences were completed by reiterative DA or
limited PCR sequencing. The most prominent gaps
between HCMV Gap4 contigs were located in (G+C)-
rich, quasirepetitive sequences at the origin of DNA
replication and in the b/b9 inverted repeat. The latter
region is hypervariable, and in most cases required PCR
sequencing for finishing.
Mutations in the HCMV genomes sequenced
By comparison with sequence data available for other
HCMV strains, the six strains sequenced in the present
study appeared to contain the full complement of wild-type
HCMV genes, with no extensive deletions. However,
several apparent mutations were identified as differences
from other strains that were predicted to ablate gene
function (Table 2). In strain 3157, gene RL13 was
frameshifted by a 2 bp insertion, and gene UL128, which
consists of three coding exons, was truncated by a
substitution in the first splice donor site (the crucial GT
dinucleotide was mutated to CT). Both of these mutations
have been reported previously from partial sequence data
(Akter et al., 2003). In addition, a substitution was present
in the first ATG codon of the gene UL40 coding region,
resulting in a change to ACG. In strain HAN13, a 17 bp
deletion caused a frameshift in gene RL5A. In strain
HAN20, a 35 bp deletion resulted in 39-truncation of the
gene US9 coding region. In strain HAN38, gene US9
contained an identical deletion and, in addition, a 17 bp
deletion caused a frameshift in gene RL6. In strain JP, gene
RL5A was frameshifted by a 2 bp deletion, and gene
UL111A, which consists of three exons, was truncated by a
38 bp deletion in a region that includes the first splice-
donor site.
DISCUSSION
Sequencing HCMV genomes
The aim of the present study was to explore the feasibility
of determining HCMV genome sequences directly from
infected cell cultures without purifying virus DNA or
constructing bacterial plasmids and, more importantly,
from clinical specimens without growing virus in cell
culture. The six HCMV strains targeted included four
grown in cell culture (3157 as purified virion DNA and
HAN13, HAN20 and HAN38 as infected cell DNA) and
two directly from clinical material (JP and 3301).
Two approaches were assessed. The first (PCR sequencing)
involved amplifying HCMV genomes as sets of overlapping
PCR products, sequencing them by the Sanger method,
acquiring reads from a standard capillary instrument and
Table 4. Results of filtering treatments for strain Towne varL
Filtering treatment k Reads after
filtering (no.)
Contig size (kb) Contigs (no.) Velvet parameter
(value)*
Median Maximum Total All .1 kb .5 kb Exp_cov Cov_cutoff
Unfiltered 21 5079235 8 25 246 237 36 16 290 42
25 5079235 14 44 246 178 30 13 250 41
Singletons removed 21 1682785 13 32 231 65 27 14 210 82
Overall quality:
.1900 21 2338321 3 16 292 765 64 16 110 11
.1700 21 4156964 7 32 264 383 46 13 220 26
25 4156964 11 32 243 150 32 16 190 44
Quality truncation,
length .29
21 2609325 7 15 242 233 36 13 65 26
Truncated to length:
40 21 5079235 14 45 251 256 21 12 190 25
25 5079235 18 44 242 114 23 12 160 38
35 21 5079235 29 65 246 176 18 8 150 26
25 5079235 31 68 242 99 13 10 110 30
30 21 5079235 24 68 240 90 20 11 105 32
25 5079235 54 68 237 61 8 7 60 24
*Each dataset was assembled using Velvet-0.7.31 (see Methods). Exp_cov, Optimal expected coverage; cov_cutoff, optimal coverage cut-off.
HCMV genomes
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assembling data using the Staden programs. Although it
was possible to benefit from efficiencies of scale by
processing strains in parallel, this approach was labour-
intensive. Nonetheless, PCR sequencing yielded complete
sequences for strains 3157, JP and HAN13, without prior
knowledge of the target sequences or additional input from
other methods. The proportions of HCMV DNA in the
3157 and JP samples are not known, and that in the
HAN13 sample was estimated at 27% (Table 3). However,
substantial regions of the strain 3301 genome were easily
PCR-sequenced for use in constructing a DA reference,
implying that this approach would succeed for samples
containing as little as 3% HCMV DNA.
The second approach (IGA sequencing) promised greater
efficiency than PCR sequencing, and involved processing
IGA data by the DA or IA strategies. We had previously
used DA to sequence samples of strains AD169 varUC and
Towne varL, containing high proportions of DNA (92 and
47%, respectively; Table 3). In the present study, we
explored the extended capabilities of IGA sequencing using
samples containing smaller proportions of HCMV DNA.
DA for strains HAN13 and 3301 was successful. However,
this assembly mode required a reference for each strain,
and this involved prior knowledge of the target sequence.
DA for strain HAN13 was straightforward, as the reference
was derived from the complete genome sequence for this
strain determined by PCR sequencing. However, DA for
strain 3301 required greater effort because the best
available reference consisted of a mosaic of 25% strain
3301 sequences (including most of the hypervariable
regions) in a backbone of 75% strain Merlin sequences.
An alternative application of DA, not requiring prior
knowledge of the target genome, would involve using a
generic, rather than a custom, reference. However, an
attempt at DA of the strain 3301 data against a generic
reference (strain Merlin) resulted in many gaps in the read
consensus, due to failure to assemble reads in regions that
are hypervariable or contain indels. Thus, although use of a
generic reference in DA would, in principle, avoid the need
to determine significant parts of the target sequence by
other methods, in practice it poses a formidable hurdle.
This state of affairs currently renders DA inadequate as a
primary means of sequencing HCMV genomes.
IA offers obvious advantages over DA for sequencing
HCMV genomes because it does not require a reference,
and thus no presumptions are made about the target
sequence. However, our initial experience of IA with single
versions of datasets (filtered or unfiltered) was disappoint-
ing, as it resulted in large numbers of small contigs (e.g. see
the outputs of individual treatments in Table 4). To
overcome this, we arrived heuristically at a process for
filtering reads and combining the IA contigs from multiple
assemblies by Phrap assembly and then Gap4 assembly
against a cognate scaffold (IAC) or a generic scaffold (IAG)
to yield a high-quality reference for DA. The involvement
of DA at this stage permitted the read alignment to be
inspected, which, given the observation that IA contigs may
contain errors, was a useful verification step. Moreover,
inspection of the read alignment facilitated resolution of
remaining ambiguities and gaps by local reiterative
assembly or PCR sequencing.
We have shown that an HCMV genome in a sample from
clinical material containing only 3% HCMV DNA can be
determined by IGA sequencing, as long as sufficient total
DNA is present in the sample. The developing capability of
IGA technology to produce greater numbers of longer
reads in paired-end form and of the assembly software to
produce more accurate, larger contigs will effectively
reduce this minimum and streamline the assembly process.
Moreover, future technologies are likely to improve the
situation further. However, two challenges remain to the
routine sequencing of complete HCMV genomes from
clinical specimens. Firstly, many samples, especially those
from healthy individuals, contain such low levels of HCMV
DNA that they will prove refractory to sequencing without
prior enrichment and amplification steps. Possibilities in
this regard include the isolation of encapsidated DNA or
the purification of virus DNA by buoyant density
centrifugation, followed by whole-genome amplification.
Secondly, many HCMV infections involve multiple strains,
and methods that facilitate physical separation of their
genomes, e.g. molecular hybridization via hypervariable
regions, BAC cloning directly from clinical sample DNA
(Zhou et al., 2009) (although this suffers from the
disadvantages mentioned above) or extended, single-
molecule sequencing, will be required in addition.
We have now added the complete genome sequences of six
HCMV strains to the three that we have already
contributed to the research field. Together with the genome
sequences of additional strains that we have not reported in
the present paper, these will provide grist for future
detailed studies of sequence variation and recombination
in HCMV.
Mutations in HCMV genomes
For the purposes of the present work, the term ‘mutation’
is used to mean a sequence difference from other strains
that is predicted to ablate gene function, as opposed to
variation, which, although also a result of mutational
processes, is not necessarily deleterious. However, it is
probable that mutations resembling variations, such as any
that might be responsible for functionally detrimental
amino acid replacements, would have escaped identifica-
tion. Thus, the mutations identified in the strains
sequenced (Table 2) were apparent because of their
locations in protein-encoding regions and probable
deleterious effects on functional protein expression. They
included indels that cause frameshifts, and substitutions
that affect initiation codons or splice sites or create
termination codons. Some of the observed mutations
occurred in genes RL5A, RL6 and RL13, which are
hypervariable members of a group of related genes called
the RL11 family.
C. Cunningham and others
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The specific mutations in genes RL13, UL40 and UL128
that characterize strain 3157 have not been identified in
other strains, and may have arisen during cell culture.
Genes RL13 and UL128 (or one of its neighbours, UL130
and UL131A) often mutate during adaptation of HCMV to
fibroblast cell culture (Akter et al., 2003; Dolan et al., 2004;
Hahn et al., 2004). Genes UL128/UL130/UL131A are
involved in entry into non-fibroblast cells (e.g. Ryckman
et al., 2008), and the function of the predicted class I
glycoprotein encoded by gene RL13 is not known. The
presence of a substitution in the first ATG codon of the
gene UL40 coding region indicates that translation occurs
either from the resulting ACG codon or from the second
ATG codon, or from both. This may be significant because
the predicted signal peptide sequence of the glycoprotein
expressed from the first ATG is similar to conserved
peptides derived from cellular major histocompatibility
complex class I molecules. These peptides bind to, and
upregulate, expression of human leukocyte antigen E
(HLA-E), which protects targets from natural killer (NK)
cell lysis by interacting with CD94/NKG2A receptors. UL40
contributes to NK cell evasion by this means (Tomasec et
al., 2000). It would be of interest to assess the HLA-E-
mediated NK evasion phenotype of strain 3157.
Neither gene RL13 nor genes UL128/UL130/UL131A are
visibly mutated in the other HCMV strains grown in cell
culture that were sequenced in the present study. However,
each strain contains other lesions. The gene RL6 mutation
in strain HAN38 has not been identified in other strains
and may have arisen during cell culture. In contrast, the
gene RL5A mutation in strain HAN13 is also present in the
independently derived strains AD169 (Davison et al., 2003)
and Davis (A. J. Davison and others, unpublished data),
thus indicating that it probably existed in the original
clinical specimens and was inherited from a common
ancestor. Also, the gene US9 mutation in strains HAN20
and HAN38 has been reported in several other HCMV
isolates (Rasmussen et al., 2003), and thus clearly
characterizes strains that circulate in the human popu-
lation. This deletion is classed as a mutation but, given its
location near the 39-end of the coding region, it is possible
that it does not ablate function and therefore amounts to a
variation. The role of gene RL5A during infection has not
been studied, and that of gene US9 during infection is not
yet known (Huber et al., 2002; Mandic et al., 2009).
In contrast to material from cell culture, where adaptation
is known to occur, it might be expected that strains in
clinical specimens would not bear mutations. Indeed, this
is apparently the case for strain 3301. However, genes RL5A
and UL111A are both mutated in strain JP. Gene UL111A
encodes viral interleukin-10 (vIL-10; Kotenko et al., 2000;
Lockridge et al., 2000), which has been proposed to have a
role in immune modulation through its effect on myeloid
cells (e.g. Chang et al., 2009). Our analysis of the sequence
of the BAC derived from strain PH (Table 1), which was
isolated from a transplant recipient suffering from HCMV
disease, identified a mutation in gene UL111A different
from that in strain JP, specifically a substitution in the
splice-acceptor site for the second exon (the crucial AG
dinucleotide is mutated to AA). However, these findings do
not necessarily indicate that HCMV strains defective in
vIL-10 expression are circulating in the human population,
as it is conceivable that expression of this function is not
advantageous, and may even be disadvantageous, to
HCMV under certain circumstances of host immunodefi-
ciency. However, it is possible that such strains are more
likely to cause disease, and thus a wider investigation of the
existence of vIL-10 mutants in immunocompromised
people, both with and without HCMV disease, would be
worthwhile.
The observations made above have given a preliminary
indication that HCMVmutants, in addition to those selected
by antiviral treatment (Chou, 2008), do indeed exist in
clinical settings. The finding that HCMV strains in some
clinical specimens contain mutations in gene UL1 (Sekulin et
al., 2007), which is another hypervariable member of the
RL11 gene family, is consistent with this perspective. An
understanding of the extent to which HCMV mutants exist
and circulate in human populations, and their potential
effects on pathogenesis, is likely to be aided by further
sequencing of HCMV genomes in clinical specimens.
METHODS
Isolation of DNA. Pertinent features of the HCMV strains analysed
are provided in Table 2. DNA for strains JP and 3301 was extracted
directly from clinical specimens, and that for the other strains was
obtained from cultures of human foreskin fibroblasts (HFFs) infected
via clinical specimens. For strain 3157, DNA was purified from cell-
released virions isolated from five 175 cm2 cell-culture flasks of
infected HFFs as described previously (McSharry et al., 2003). For
strain JP, DNA was purified from 0.1 g prostate gland tissue using the
NucliSENS easyMAG extraction system (bioMe´rieux). For strains
HAN13, HAN20 and HAN38, DNA was purified from a 75 cm2 cell-
culture flask of infected HFFs using a QIAamp 96 DNA Blood kit
(Qiagen), and the numbers of virus genomes per cell were measured
by standard methods at 44 417, 13 345 and 10 000, respectively
(Engelmann et al., 2008; Wandinger et al., 2000). For strain 3301,
12 ml urine was centrifuged at 25 000 g for 1 h, and DNA was
purified from the pellet as described previously (McSharry et al.,
2003). DNA concentrations were estimated by agarose gel electro-
phoresis followed by ethidium bromide staining.
PCR sequencing. A library of conserved, HCMV-specific primers
for generating and sequencing PCR products was designed from data
available for published complete HCMV genomes or substantial
portions thereof (Table 1; Dolan et al., 2004). The primer list is
available from the corresponding author. PCR primers (usually 24 nt)
were positioned so that each product overlapped its neighbours by
100–300 bp. In general, sequencing primers (usually 18 nt) were
located on each DNA strand at about 500 nt intervals, so that the
distance between any primer and its nearest neighbours on the
opposing strand was about 250 nt. During the process of deriving
genome sequences for a series of HCMV strains, primers were refined
reiteratively in order to maximize conservation and effectiveness. The
current number of PCR products is 105 (mean size, 2.5 kbp), and the
total number of PCR and sequencing primers is 1121. Allele-specific
primers were used for some hypervariable regions.
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PCRs were carried out under two sets of conditions, using Advantage
2 DNA polymerase with the proprietary PCR buffer (Clontech).
Details of the conditions applied to specific PCR products are
available from the corresponding author. The first set of conditions
was used to generate the majority of products, and involved a 50 ml
reaction in 16 PCR buffer containing sample DNA (the amount
being determined empirically), 0.2 mM each PCR primer (Sigma-
Genosys), dNTPs (0.2 mM each) and 1 ml DNA polymerase (both
from Clontech). The PCR program was conducted in a GeneAmp
PCR system 9700 instrument (Applied Biosystems), and consisted of
heating the reaction mixture at 95 uC for 2 min, followed by 35 cycles
at 95 uC for 45 s, 60 uC for 30 s and 68 uC for 1 min kbp21, and
holding at 4 uC. The second set of conditions involved a 50 ml
reaction in 16 PCR buffer containing sample DNA, 0.2 mM each
PCR primer, dNTPs (0.2 mM each), 1.6 M betaine (Sigma-Aldrich)
and 1 ml DNA polymerase. The PCR program consisted of heating the
reaction mixture at 96 uC for 5 min, followed by 35 cycles at 94 uC
for 15 s, 62 uC for 40 s and 68 uC for 1 min kbp21, and holding at
4 uC.
The PCR products were isolated by agarose gel electrophoresis and
purified by using a GENECLEAN Turbo kit (MP Biomedicals). Most
PCR products were sequenced directly, but some were cloned into
pGEM-T (Promega) and, for each product, four to six plasmids were
sequenced.
Sequencing reactions were set up in 96-well PCR trays using
proprietary reagents (Applied Biosystems). The 10 ml reactions in
0.8756 PCR buffer consisted of purified PCR product (the amount
being determined empirically), 0.32 mM sequencing primer (Sigma-
Genosys) and 0.5 ml BigDyes (Applied Biosystems) containing DNA
polymerase. The thermal program consisted of heating at 96 uC for
4 min, followed by 25 cycles at 96 uC for 10 s, 50 uC for 5 s and 60 uC
for 4 min, and holding at 4 uC. Sequence data were generated at the
BHF Glasgow Cardiovascular Research Centre (University of
Glasgow) using an Applied Biosystems 3730 instrument.
Sequence databases were compiled from the electropherogram files by
using Pregap4, Gap4 (Staden et al., 2000) and Phred (Ewing & Green,
1998; Ewing et al., 1998). The genome sequences were reconstructed
from the final, edited databases after locating the genome termini by
comparison with those determined experimentally for strain Merlin
(Dolan et al., 2004).
IGA sequencing. Sequence datasets for strains HAN13, HAN20,
HAN38 and 3301, each consisting of several million single-end reads
with associated quality data, were generated from DNA samples using
an IGA operated according to the manufacturer’s protocols at the
GenePool (University of Edinburgh). Methodological information is
available at http://www.illumina.com. The amount of DNA submitted
for strains HAN13, HAN20 and HAN38 was approximately 1–4 mg.
The strain 3301 sample contained less DNA, and a nominal amount
(approx. 0.1 mg, corresponding to 2 ml urine) was submitted.
Processing IGA data by reference-dependent assembly. The
reference consisted of an appropriate HCMV genome sequence
trimmed of the inverted repeats (ac and ba) at the genome termini,
except for 50 nt regions proximal to the beginning of UL and the end
of US, in order to minimize ambiguities due to the inverted repeats.
The reads were aligned with the reference using Maq-0.6.8, and the
alignment of reads with the reference and read consensus was
inspected by using Maqview-0.2.1 (Li et al., 2008; http://maq.sourceforge.
net). The reference was then improved by reiterative DA, employ-
ing the whole sequence or substrings thereof (local reiterative DA),
until the final reference matched the read alignment. As a last step,
the read consensus was extracted and aligned with the reference by
using MAFFT-6.240 (Katoh et al., 2005), and any differences were
inspected in the read alignment. Discrepancies and gaps in the
read consensus due to lack of coverage were resolved by PCR
sequencing, and differences due to poor base calling at specific
locations in reads on one strand or to SNPs were noted.
Processing IGA data by reference-independent assembly. The
IGA data were processed in five stages, which are expanded below: (i)
filtering the reads by a range of treatments, (ii) IA of each resulting
dataset to generate contigs consisting of HCMV or cellular sequences,
(iii) Phrap assembly of all of the IA contigs combined from the
assemblies to generate Phrap contigs, (iv) Gap4 assembly of the Phrap
contigs against an HCMV genome scaffold to generate HCMV Gap4
contigs, and (v) DA of the IGA data using a reference constructed
from the HCMV Gap4 contigs. The stages of this process were
enabled and connected by using Perl scripts, which are available from
the corresponding author.
(i) The reads in each IGA dataset were examined for singletons
(unique reads), overall quality, and quality at each base. They were
filtered by removing singletons, removing reads below a minimum
overall quality, truncating reads at the point where perfect quality
ceased (quality truncation) or truncating reads to a set length, or
combinations of these steps. The filtering treatments used for each
dataset were chosen empirically on the basis of the IA output, with a
preference for those that reduced the number of reads by
approximately 20–60%. Details of the filtering treatments used are
listed in Table 5.
(ii) Each unfiltered or filtered dataset was assembled by using Velvet-
0.7.31 (Zerbino & Birney, 2008; http://www.ebi.ac.uk/~zerbino/
velvet). Velvet uses a de Bruijn graph method to represent the reads
in terms of words of hash length k, which is a number smaller than
the read length (50 nt). The default value used was k521, but k525,
27 or 29 occasionally yielded longer contigs. Details of the values of k
used are listed in Table 5. For initial assembly of each dataset, the
Velvet parameters exp_cov (optimal expected coverage) and cov_cut-
off (optimal coverage cut-off) were set to 1 and 0, respectively. The
filtered reads were then reassembled with exp_cov optimized with the
aid of functions in the R plotrix package (accessible via Velvet) and
employed at all cov_cutoff values between 0 and 200. The optimal
cov_cutoff value was defined as that at which the median and
maximum contig sizes were greatest. The contigs (with no minimum
length threshold set) were then collected for each dataset version at
the optimal values of cov_cutoff and exp_cov. All IA contigs from the
filtered datasets were pooled, and duplicates and substrings of other
contigs were identified and removed.
(iii) The pooled, non-redundant IA contigs were assembled into
larger contigs by using Phrap-1.080812 (http://www.phrap.org) with
default parameters.
(iv) The Phrap contigs were aligned with an HCMV genome scaffold
using Gap4, thus retaining only those contigs (HCMV Phrap
contigs) that originated from the virus genome. Two alternative
scaffolds were used in processes denoted IAC and IAG. For IAC, a
cognate scaffold was fashioned (at least in part) from the sequence of
the relevant strain determined by other methods. For IAG, a generic
scaffold was constructed from the strain Merlin sequence. The
HCMV Phrap contigs often exhibited clusters of sequence differ-
ences from the scaffold adjoining their ends, probably as a result of
erroneous alignments that had terminated the IA contigs. These
mismatched bases were removed. HCMV Phrap contigs that
overlapped each other were then joined, yielding a set of HCMV
Gap4 contigs.
(v) A reference consisting of the HCMV Gap4 contigs with any gaps
patched by parts of the cognate or generic scaffold was used for DA.
The reference was then improved and the sequence finished by
reiterative DA and PCR sequencing, as described above.
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